[1]Scheinfeld N.A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept,infliximab and adalimumab[J].J Dermatolog Treat,2004,15(5):280-294[2]Graham,TR,Odero-Marah,VA,Chung,LW,et al.PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells[J].Prostate,2009,69(2):168-180[3]Hayes AJ,Neuhaus SJ,Clark MA,et al.Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-t1 sarcoma[J].Ann Surg Oncol,2007,14(1):230-238[4]Lee Y,Schwarz E,Davies M,et al.Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone[J].J Orthop Res,2003,21(1):62-72[5]Soares AF,Xavier RL,da Costa Miguel MC,et al.Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma[J].Am J Otolaryngol,2010,31(4):266-271[6]Nakashima M,Reddi AH.The application of bone morphogenetic proteins to dental t9 engineering[J].Nat Biotechnol,2003,21(9):1025-1032[7]CaoY,Slaney CY,Bidwell BN,et al.BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity[J].Cancer Res,2014,74(18):5091-5102[8]Kim IY,Lee DH,Ahn HJ,et al.Expression of bone morphogenetic protein receptors Type-IA,-IB,and -II correlates with tumor grade in human prostate cancer t11s[J].Cancer Res,2000,60(11):2840-2844[9]Andréa Ferreira Soares,Ruth Lopes de Freitas Xavier,Márcia Cristina da Costa Miguel,et al.Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma[J].AM J OTOLARYNG,2010,31(4):266-271[10]薛立伟,张君,王旭霞,等.肿瘤坏死因子-α对大鼠成骨细胞生长影响的实验研究[J].华西口腔医学杂志,2009,27(4):378-380[11]Guo HH,Yu CC,Sun SX,et al.Adenovirus-mediated siRNA targeting TNF-alpha and overexpression of bone morphogenetic protein-2 promotes early osteoblast differentiation on a cell model of Ti particle- induced inflammatory response in vitro[J].Braz J Med Biol Res,2013,46(10):831-838[12]Matsumoto Y,Otsuka F,Takano M,,et al.Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor- in C2C12 cells [J].Mol Cell Endocrinol,2010,325 (1/2) 118–127[13] Takano M,Otsuka F,Matsumoto Y,et al.Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α. [J]. Mol Cell Endocrinol,2012,348 (1) 224–232[14]孙玮,张君,王乐秀,等.BMP-2与 TNF-α对成骨细胞增殖和分化作用的比较分析[J].口腔医学,2014,34(9):651-[15]Singhatanadgit W,Salih V,Olsen I.OlsenBone morphogenetic proteinreceptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-α in human bone cells[J]..Int J Biochem Cell Biol,2006,38(10):1794-1807[16]Geiger M,Li RH,Friess W.Collagen sponges for bone regenerationwith rhBMP-2[J].Adv Drug Deliv Rev,2003,55(12):1613-1629[17]Katagiri T,Tsukamoto S.The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway[J].Biol Chem,2013,394(6):703-714[18]Chen D,Zhao M,Mundy GR.Bone Morphogenetic Proteins[J].Growth Factors,2004,22(4):233-241[19]Liu G,Cheng J,Guan G,et al.Renal lymph circulation blockage altersthe epithelial cell phenotype and tubular integrity: role of distinct regulation of BMP7 and TGF-beta/Smadssignaling pathway[J].Int Urol Nephrol,2014,46(6):1239-1246[20]Cho SY,Ha SY,Huang SM,et al.The prognosticsignificance of Smad3,Smad4,Smad3 phosphoisoform expression inesophageal squamous cell carcinoma[J].Med Oncol,2014,31(11):236- |